Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review

Background. Intravenous tPA (tissue plasminogen activator) therapy remains underutilized in patients with Acute Ischemic Stroke (AIS). Anecdotal data indicates that physicians are increasingly liable for administering and for failure to administer tPA. Methods. An extensive search of Medline, Embase...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhatt, Archit, Safdar, Adnan, Chaudhari, Dhara, Clark, Diane, Pollak, Amber, Majid, Arshad, Kassab, Mounzer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777130/
https://www.ncbi.nlm.nih.gov/pubmed/24083048
http://dx.doi.org/10.1155/2013/562564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777130/
https://www.ncbi.nlm.nih.gov/pubmed/24083048
http://dx.doi.org/10.1155/2013/562564

Ejemplares similares